Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Am J Ophthalmol. 2017 Jan 17;176:102–107. doi: 10.1016/j.ajo.2017.01.004

Table 3.

Quality of life measures showing Short Form-36 Physical Component scores by group at six and 12 months.

Group SF-36 score St Dev SF improvement P value
ACZ to open-label ACZ 51.7 7.51
52.28 8.08 0.58 0.67
PLB to open-label ACZ 49.51 8.69
51.56 8.48 2.05 0.05
ACZ tapered off ACZ 52.38 5.76
53.51 8.60 1.13 0.53
PLB to no ACZ 55.26 4.66
57.11 3.71 1.85 0.26

ACZ = acetazolamide, PLB = placebo, SF = short form